Stay updated on Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.

Latest updates to the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page
- Check7 days agoChange DetectedA site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record.SummaryDifference0.6%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check20 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check41 days agoChange DetectedA new revision v3.7.0 has been added to the record history, replacing the previous v3.6.6.SummaryDifference0.2%

- Check62 days agoChange DetectedA new revision entry v3.6.6 is added to the page's history, updating the version shown in the record. This reflects a small system update rather than changes to study information or page content.SummaryDifference0.1%

- Check84 days agoChange DetectedThe history now shows a new revision entry (v3.6.5) replacing the previous v3.6.4, signaling an updated version of the page. This represents a routine system update to the study record history rather than a change to the study data.SummaryDifference0.1%

Stay in the know with updates to Lanadelumab in Preventing Angioedema Attacks Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in Preventing Angioedema Attacks Clinical Trial page.